Get startedLog in
    Picture of Takeda Pharmaceutical logo

    TAK — Takeda Pharmaceutical News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    All News

    Brief: Takeda Pharmaceutical Conducted Thorough Assessment, Found There Was No Confirmed Causal Relationship To Use Of Adzynma &Patient Death - Spokesperson

    Picture of Takeda Pharmaceutical logoTakeda Pharmaceutical
    21/11/2025 21:53
    Nov 21 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T:

TAKEDA PHARMACEUTICAL: CONDUCTED THOROUGH ASSESSMENT, FOUND THERE WAS NO CONFIRMED CAUSAL RELATIONSHIP TO USE OF ADZYNMA &PATIENT DEATH - SPOKESPERSON

Further company coverage: 4502.T

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Takeda Pharmaceutical

    See all news